tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Balance Sheet

140 Followers

Gain Therapeutics Balance Sheet

Gain Therapeutics's total assets for Q4 2023 were $18.61M, an increase of 32.00% from the previous quarter. GANX total liabilities were $6.03M for the fiscal quarter, a -10.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 18.61M$ 24.10M$ 38.99M$ 9.60M$ 660.29K
Total Liabilities
$ 6.03M$ 5.22M$ 4.17M$ 3.40M$ 1.11M
Total Equity Gross Minority
$ 12.58M$ 18.88M$ 34.82M$ 6.20M$ -449.86K
Total Capitalization
$ 13.71M$ 20.31M$ 35.41M$ 6.92M$ -449.86K
Preferred Stock Equity
---$ 415.00$ 99.00
Capital Lease Obligations
---$ 523.08K$ 200.95K
Currency in USD

Gain Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis